Last update:

Oncology news

Liver tumors may depend on LARS to withstand stress and keep multiplying

Illinois researchers made a breakthrough discovery in the fight against liver cancer. Collaborators Lin-Feng Chen, Susan A. Martinis, and graduate student Xiaodan Lin found that decreasing protein levels of leucyl-tRNA synthetase ...

AI blood assay detects liver cancer across diverse international populations

Researchers at the Johns Hopkins Kimmel Cancer Center validated an artificial intelligence (AI)-powered blood test that accurately detected liver cancer in people from two geographically and biologically distinct populations ...

Human tissue model tracks glioblastoma invasion cell by cell

Glioblastoma is a malignant brain tumor and is among the most aggressive cancers in humans. Despite multimodal therapy with surgery, radiation and chemotherapy, there is still no cure. A major reason is the tumor's invasive ...

Scientists decode cancer's most effective survival strategy

In the intricate biology of the human body, organs such as the breast, the colon and the lungs are lined with a defensive barrier known as the epithelium. At the heart of this barrier sits a remarkable protein called Mucin-1 ...

New marker uses tomography to refine gastric cancer prognosis

Researchers at the State University of Campinas (UNICAMP) in São Paulo, Brazil, have identified a new biomarker that may help determine the prognosis for patients with gastric cancer, the fifth most common type of cancer ...

Rural areas lag behind in cancer treatment and prevention

Cancer in the United States experienced a dramatic turnaround in 1991. Prior to that year, cancer deaths had been increasing for decades, peaking at 215 deaths per 100,000 people, meaning about 1 in 4 deaths were attributed ...

FDA expands use of kidney cancer drug belzutifan

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier-stage kidney cancers in ...